NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered PT-141 from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it for free.

Test my supply
+14 more ↓
56%
Finnrick rating
#41 of 44 PT-141 vendors
0 of 2 classifiable tests passed
natural 0%
methodology · Purity focus
Finnrick analysis · PT-141

Tianjin Ruiwang's purity-focus record is strongest for GHK-Cu, while Retatrutide and Tirzepatide look batch-dependent with recent recovery after purity, identity, and fill misses. TB-500 and Tesamorelin are weaker, with 0 mg identity failures, volatile fills or purity swings, and intermittent batch IDs across a recent but dispersed record.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Ruiwang New Material Technology Co

Corporate filings, archived B2B pages, and trade data trace Tianjin Ruiwang from industrial materials into a peptide-facing sales buildout. The report maps the UK shell, Hebei control trail, domain migration, Shenzhen shipping lead, and batch-number gaps.

27 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
86%
22
2
Retatrutide
$0.90
80%
65
3
Tirzepatide
$0.47
76%
33
4
Ipamorelin
$0.77
65%
5
6
PT-141selected
$0.55
56%
2
7
Cagrilintide
$2.20
51%
3
8
BPC-157
$0.90
48%
14
9
Tesamorelin
$2.05
43%
18
10
TB-500
$1.32
27%
8
11
5-Amino-1MQ
$0.30
-
0
12
CJC-IPA
$1.00
-
0
13
Glutathione
$0.01
-
0
14
hCG
-
-
0
15
Kisspeptin
$1.12
-
0
16
KPV
$0.77
-
0
17
Melanotan I
$0.40
-
0
18
MOTS-c
$0.66
-
0
19
NAD+
$0.01
-
0
20
Oxytocin
$1.45
-
0
21
Semax
$0.60
-
0
23
Wolverine
$0.99
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Nov 2025: 54%28 Apr 2026: 53%29 Sept 2026: current 56%54%53%56%Nov 25Sep 26
Showing PT-141 tests only
Tianjin Ruiwang New Material Technology Co PT-141 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
28 Apr 2026Fail
Tested
lab nameView COA
25 Nov 2025Fail
Tested
lab nameView COA

About Tianjin Ruiwang New Material Technology Co test results from Finnrick

Tianjin Ruiwang New Material Technology Co is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 175 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Ruiwang New Material Technology Co peptides in this dataset are BPC-157 (14 tests), Cagrilintide (3 tests) and GHK-Cu (22 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 175 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered PT-141 from Tianjin Ruiwang New Material Technology Co? Mail in a sample (US only) and let us test it for free.

Test my supply